The Division of Surgery of the Manchester Royal Infirmary provides clinical surgical services for the population of central Manchester and also houses a broad range of disciplines providing complex tertiary care surgery for the wider community of Greater Manchester and the North West Region of England.
Over the last two years, the Manchester Vascular Centre has established a broad portfolio of commercial studies comprising of research on medical devices, new drug treatments, stents and related aneurysm surgery, in which they are major recruiters, as well as collaborating with the molecular work with Manchester Metropolitan University. The team have also contributed to many national, academic, NIHR HTA funded studies looking to find the best possible surgical or endovascular treatment for patients with conditions such as severe limb ischemia or a thoracic aneurysm.
Ear, Nose & Throat (ENT) surgery has benefited from pioneering work on cochlear implantation as a clinical service and Manchester is also recognised for audiology research. Recently the team were also recognised as the highest recruiting centre for the study of a new drug that aimed to improve the performance of cochlear implants in patients relying on these devices to hear.
We also have an active and well-recognised hepatopancreatobiliary surgical research programme which has focused on biomarkers of hepatic and pancreato-biliary (HPB) cancer, mechanisms of acinar cell injury in acute pancreatitis and laparoscopic HPB surgery.
The Surgery Research Team also supports a large portfolio of Colorectal studies that encompasses research into both Solid Tumour Cancer research, and General Surgery. Manchester University NHS Foundation Trust is the sponsor and Chief Investigator for a number of studies in this area, which are funded by National Institute for Health Research (NIHR) Grants. Professor James Hill is the Chief Investigator for CREST-2 and PPAC2.
The Surgery Research Team work in close partnership with The Christie NHS Foundation Trust to deliver shared care Cancer Research.